Outpost Bio secures a £2.6m pre-seed round led by Merantix Capital and Seedcamp to make human microbiology computable

Outpost Bio builds biological models that analyse how microbial communities in and on the human body affect drugs, nutrients, and health outcomes. Its platform helps pharmaceutical, food, and consumer companies test how products interact with human microbiology to reduce risk and improve design.